Dihydroergotamine (injection): Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
Gerald Chi (talk | contribs) m Changed protection level for "Dihydroergotamine" ([Edit=Allow only autoconfirmed users] (expires 02:02, 19 February 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 02:02, 19 February 2014 (UTC))) |
(No difference)
|
Revision as of 02:02, 5 February 2014
Clinical data | |
---|---|
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 9 hours |
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C33H37N5O5 |
Molar mass | 583.678 g/mol |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dihydroergotamine is an ergot alkaloid used to treat migraines.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Lysergamides